JPH09315930A - Cosmetic material for skin - Google Patents
Cosmetic material for skinInfo
- Publication number
- JPH09315930A JPH09315930A JP8157730A JP15773096A JPH09315930A JP H09315930 A JPH09315930 A JP H09315930A JP 8157730 A JP8157730 A JP 8157730A JP 15773096 A JP15773096 A JP 15773096A JP H09315930 A JPH09315930 A JP H09315930A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- extract
- mevalonic acid
- effect
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 25
- 239000000463 material Substances 0.000 title abstract 6
- 239000000284 extract Substances 0.000 claims abstract description 30
- KJTLQQUUPVSXIM-ZCFIWIBFSA-N (R)-mevalonic acid Chemical compound OCC[C@](O)(C)CC(O)=O KJTLQQUUPVSXIM-ZCFIWIBFSA-N 0.000 claims abstract description 22
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 claims abstract description 15
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 15
- JYVXNLLUYHCIIH-UHFFFAOYSA-N (+/-)-mevalonolactone Natural products CC1(O)CCOC(=O)C1 JYVXNLLUYHCIIH-UHFFFAOYSA-N 0.000 claims abstract description 14
- JYVXNLLUYHCIIH-ZCFIWIBFSA-N R-mevalonolactone, (-)- Chemical compound C[C@@]1(O)CCOC(=O)C1 JYVXNLLUYHCIIH-ZCFIWIBFSA-N 0.000 claims abstract description 13
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 8
- 108010035532 Collagen Proteins 0.000 claims abstract description 8
- 102000008186 Collagen Human genes 0.000 claims abstract description 8
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 8
- 229920001436 collagen Polymers 0.000 claims abstract description 8
- 244000061508 Eriobotrya japonica Species 0.000 claims abstract description 7
- 235000009008 Eriobotrya japonica Nutrition 0.000 claims abstract description 7
- 239000008280 blood Substances 0.000 claims abstract description 7
- 210000004369 blood Anatomy 0.000 claims abstract description 7
- 239000000419 plant extract Substances 0.000 claims abstract description 6
- 244000280244 Luffa acutangula Species 0.000 claims abstract description 5
- 235000009814 Luffa aegyptiaca Nutrition 0.000 claims abstract description 5
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 4
- 235000008434 ginseng Nutrition 0.000 claims abstract description 4
- 240000001548 Camellia japonica Species 0.000 claims description 8
- 241001122767 Theaceae Species 0.000 claims description 8
- 235000018597 common camellia Nutrition 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- 229940041514 candida albicans extract Drugs 0.000 claims description 6
- 239000012138 yeast extract Substances 0.000 claims description 6
- 244000134552 Plantago ovata Species 0.000 claims description 5
- 235000003421 Plantago ovata Nutrition 0.000 claims description 5
- 239000009223 Psyllium Substances 0.000 claims description 5
- 229940070687 psyllium Drugs 0.000 claims description 5
- 235000002020 sage Nutrition 0.000 claims description 5
- 241001116389 Aloe Species 0.000 claims description 4
- 235000011399 aloe vera Nutrition 0.000 claims description 4
- 235000019512 sardine Nutrition 0.000 claims description 4
- 241000332371 Abutilon x hybridum Species 0.000 claims description 3
- 240000002234 Allium sativum Species 0.000 claims description 3
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 3
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 3
- 235000018185 Betula X alpestris Nutrition 0.000 claims description 3
- 235000018212 Betula X uliginosa Nutrition 0.000 claims description 3
- 240000006927 Foeniculum vulgare Species 0.000 claims description 3
- 235000004204 Foeniculum vulgare Nutrition 0.000 claims description 3
- 235000011201 Ginkgo Nutrition 0.000 claims description 3
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 3
- 244000194101 Ginkgo biloba Species 0.000 claims description 3
- 241000208690 Hamamelis Species 0.000 claims description 3
- 244000170916 Paeonia officinalis Species 0.000 claims description 3
- 240000004371 Panax ginseng Species 0.000 claims description 3
- 244000082204 Phyllostachys viridis Species 0.000 claims description 3
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 3
- 244000126014 Valeriana officinalis Species 0.000 claims description 3
- 235000013832 Valeriana officinalis Nutrition 0.000 claims description 3
- 244000273928 Zingiber officinale Species 0.000 claims description 3
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 3
- 239000011425 bamboo Substances 0.000 claims description 3
- -1 button pi Substances 0.000 claims description 3
- 235000004611 garlic Nutrition 0.000 claims description 3
- 235000008397 ginger Nutrition 0.000 claims description 3
- 235000016788 valerian Nutrition 0.000 claims description 3
- 240000003538 Chamaemelum nobile Species 0.000 claims description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims 1
- 241000218228 Humulus Species 0.000 claims 1
- 241000238633 Odonata Species 0.000 claims 1
- 241000282577 Pan troglodytes Species 0.000 claims 1
- 241001125046 Sardina pilchardus Species 0.000 claims 1
- 235000017803 cinnamon Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 41
- 230000002500 effect on skin Effects 0.000 abstract description 4
- 241000124008 Mammalia Species 0.000 abstract description 3
- 241000196324 Embryophyta Species 0.000 abstract description 2
- 229940057061 mevalonolactone Drugs 0.000 abstract 2
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 241000736199 Paeonia Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 56
- 238000012360 testing method Methods 0.000 description 20
- 239000000203 mixture Substances 0.000 description 12
- 239000002994 raw material Substances 0.000 description 12
- 230000007306 turnover Effects 0.000 description 12
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000002884 skin cream Substances 0.000 description 9
- 102000011782 Keratins Human genes 0.000 description 8
- 108010076876 Keratins Proteins 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 235000013399 edible fruits Nutrition 0.000 description 7
- 210000000434 stratum corneum Anatomy 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 230000009759 skin aging Effects 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- 208000035404 Autolysis Diseases 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 206010057248 Cell death Diseases 0.000 description 3
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241001125048 Sardina Species 0.000 description 3
- 239000001140 aloe barbadensis leaf extract Substances 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000003405 preventing effect Effects 0.000 description 3
- 230000028043 self proteolysis Effects 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 235000008694 Humulus lupulus Nutrition 0.000 description 2
- 244000025221 Humulus lupulus Species 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 241001147748 Lactobacillus heterohiochii Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000010676 Ocimum basilicum Nutrition 0.000 description 1
- 240000007926 Ocimum gratissimum Species 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940070641 chamomile flowers Drugs 0.000 description 1
- 229940017545 cinnamon bark Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000035322 succinylation Effects 0.000 description 1
- 238000010613 succinylation reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、皮膚化粧料に関
し、更に詳しくは、優れた皮膚の老化防止効果(荒れ肌
改善効果、角質改善効果、ターンオーバー速度を早くす
る効果)、美肌効果を発現、付与することに優れた皮膚
化粧料に関する。TECHNICAL FIELD The present invention relates to a skin cosmetic, and more specifically, it exhibits an excellent anti-aging effect on skin (effect of improving rough skin, effect of improving keratin, effect of accelerating turnover speed), and beautiful skin effect. The present invention relates to a skin cosmetic which is excellent in giving.
【0002】[0002]
【従来の技術】老化した皮膚は、乾燥して滑らかさのな
い荒れ肌となり、角質細胞剥離現象が認められる。そし
て老化した皮膚は、ターンオーバー速度が遅く、また皮
膚に老化防止効果が発現、付与されると、皮膚のターン
オーバー速度が早くなると言われている。従来、皮膚表
面に適度な湿潤感及び柔軟性を与える化粧料は種々提案
され、例えば特開平4−99707号公報では、R−
(−)メバロン酸を含有する皮膚化粧料が提案されてい
る。また、皮膚に湿潤感を与えるために、皮膚化粧料中
に保湿剤として、プロピレングリコール、1,3ブチレ
ングリコール、グリセリン、ポリグリセリン等を配合す
ることも行われているが、保湿効果を得るためには、こ
れらの保湿剤を5重量%以上の多量に配合するためベタ
ツキ感が生じる欠点があった。また、上記皮膚化粧料等
は、皮膚組織の表皮へ作用するが、表皮の下の組織であ
る真皮にも作用することは少なく、従って、上記の様な
皮膚の老化防止に十分な効果を有するものはなかった。2. Description of the Related Art Aged skin becomes rough and dry without smoothness, and keratinocyte exfoliation is observed. It is said that aging skin has a slow turnover speed, and that when the antiaging effect is exerted and imparted to the skin, the turnover speed of the skin increases. Conventionally, various cosmetics that impart a suitable moist feeling and flexibility to the skin surface have been proposed. For example, in Japanese Patent Application Laid-Open No. 4-99707, R-
(-) Skin cosmetics containing mevalonic acid have been proposed. In addition, propylene glycol, 1,3-butylene glycol, glycerin, polyglycerin, and the like have been added as a humectant in skin cosmetics to give a moist feeling to the skin. Has a drawback that stickiness is caused because these humectants are incorporated in a large amount of 5% by weight or more. In addition, the skin cosmetics and the like act on the epidermis of the skin tissue, but rarely act on the dermis, which is a tissue below the epidermis, and thus have a sufficient effect on the prevention of skin aging as described above. There was nothing.
【0003】[0003]
【発明が解決しようとする課題】本発明の目的は、老化
防止効果(荒れ肌改善効果、角質改善効果、ターンオー
バー速度を早くする効果)、美肌効果、及び優れた使用
感を発現、付与する皮膚化粧料を提供することにある。DISCLOSURE OF THE INVENTION The object of the present invention is to develop and impart an anti-aging effect (rough skin improving effect, keratin improving effect, turnover speed increasing effect), beautiful skin effect, and excellent feeling of use. To provide cosmetics.
【0004】[0004]
【課題を解決するための手段】上記の目的は、(a)メ
バロン酸、メバロン酸ラクトンの一種以上と、(b)ビ
ワ、桃、アロエ、高麗ニンジン、ヘチマ、芍薬、オオレ
ン、オオバク、ボタンピ、ゲンノショウコ、茶、クジ
ン、オドリコソウ、セージ、ハマメリス、バーチ、ニン
ニク、チンピ、カミツレ、シャゼンソウ、桔梗、ケイ
ヒ、ウイキョウ、ホップ、カノコソウ、オウゴン、ムラ
サキ、セージ、銀杏、竹、ソウハクヒ、センブリ、椿か
らなる群の一種以上から選ばれる植物抽出物とを含有す
る皮膚化粧料によって達成される。[Means for Solving the Problems] The above objects are (a) one or more of mevalonic acid and mevalonic acid lactone, and (b) loquat, peach, aloe, ginseng, loofah, peony, oleen, psyllium, button pi, Gentian ginger, tea, spruce, sardine, sage, hamamelis, birch, garlic, chinpi, chamomile, chazensou, bellflower, keihi, fennel, hops, valerian, sardine, purple, sage, ginkgo, bamboo, sowaku, senburi, camellia, camellia It is achieved by a skin cosmetic containing a plant extract selected from one or more of:
【0005】又、(a)メバロン酸、メバロン酸ラクト
ンの一種以上と、(b)酵母粉末、酵母抽出物の一種以
上とを含有する皮膚化粧料によって達成される。Further, it is achieved by a skin cosmetic containing (a) one or more of mevalonic acid and mevalonic acid lactone and (b) one or more of yeast powder and yeast extract.
【0006】更に、(a)メバロン酸、メバロン酸ラク
トンから選ばれる一種以上と、(b)哺乳動物の血液か
らの除蛋白抽出物、コラーゲンの一種以上とを含有する
皮膚化粧料によって達成される。Further, it is achieved by a skin cosmetic composition containing (a) one or more kinds selected from mevalonic acid and mevalonic acid lactone, and (b) one or more kinds of deproteinized protein extract from mammalian blood and collagen. .
【0007】[0007]
【発明の実施の形態】本発明で、(a)成分として使用
するメバロン酸は火落酸(分子式:C6 H12O4 )とも
言い、清酒中に混入した真性火落菌(Lactobac
illushomohiochi及びL.hetero
hiochi)の不可欠生育因子、及び乳酸菌(L.a
cidophillus)の生育促進因子として発見さ
れた物質であり、ステロール等のイソプレノイド系化合
物の生合成前駆体、又は各種光学活性物質の化学的もし
くは酵素的合成原料に利用される。そしてメバロン酸に
は、2種類の異性体〔R(−)−メバロン酸、S(+)
−メバロン酸〕が存在し、天然に存在するのはR(−)
−メバロン酸であるが、本発明には、その何れも使用出
来るが、入手が容易なR(−)−メバロン酸が好まし
い。R(−)−メバロン酸は、例えば、特開昭63−2
16484号公報、特開昭63−216485号公報、
特開昭63−216486号公報、特開昭63−216
487号公報等に記載された微生物発酵方法によって製
造出来る。又は、化学的合成方法によってラセミ体(異
性体混合物)として製造が出来、しかも各異性体に単離
も可能であり、本発明ではそのいずれでも使用出来る。
更に、本発明で(a)成分として使用するメバロン酸の
誘導体であるメバロン酸ラクトン(分子式:C6 H10O
3 )は、加水分解することにより容易にメバロン酸に変
化する性質を有する化合物である。BEST MODE FOR CARRYING OUT THE INVENTION In the present invention, the mevalonic acid used as the component (a) is also referred to as pyroclastic acid (molecular formula: C 6 H 12 O 4 ), and true fire bacillus (Lactobac) mixed in sake.
illushomochio and L. hetero
chichi), and lactic acid bacteria (L. a.
Cidophilus), a substance found as a growth-promoting factor, and is used as a biosynthesis precursor for isoprenoid compounds such as sterols, or as a raw material for chemically or enzymatically synthesizing various optically active substances. Mevalonic acid has two isomers [R (-)-mevalonic acid, S (+)
-Mevalonic acid] and R (-)
-Mevalonic acid, any of which can be used in the present invention, but R (-)-mevalonic acid, which is easily available, is preferable. R (-)-mevalonic acid is disclosed in, for example, JP-A-63-2
No. 16484, JP-A-63-216485,
JP-A-63-216486, JP-A-63-216
No. 487 can be produced by a microbial fermentation method. Alternatively, it can be produced as a racemate (mixture of isomers) by a chemical synthesis method, and can be isolated into each isomer, and any of them can be used in the present invention.
Further, mevalonic acid lactone (molecular formula: C 6 H 10 O) which is a derivative of mevalonic acid used as the component (a) in the present invention.
3 ) is a compound having the property of being easily converted to mevalonic acid by hydrolysis.
【0008】上記のメバロン酸、メバロン酸ラクトンの
皮膚化粧料への配合量は、皮膚化粧料全量に対して、
0.001〜10重量%(以下、wt%と略記する。)
が好ましい。0.001wt%未満では本発明の効果が
十分に発揮されず、10wt%を超えて配合しても、配
合量の増加に見合った効果が期待出来ない場合がある。The amount of the above mevalonic acid or mevalonic acid lactone to be added to the skin cosmetics is based on the total amount of the skin cosmetics.
0.001 to 10% by weight (hereinafter abbreviated as wt%)
Is preferred. If it is less than 0.001 wt%, the effect of the present invention is not sufficiently exhibited, and if it is compounded in excess of 10 wt%, the effect commensurate with the increase of the compounding amount may not be expected.
【0009】一方、本発明で(b)成分として使用す
る、前記の植物抽出物としては、例えば、ビワ、桃、ア
ロエ、銀杏では葉、茶は葉又は実、高麗ニンジン、芍
薬、カノコソウ、ムラサキ、桔梗は根、ヘチマ、ゲンノ
ショウコ、オドリコソウ、竹は地上部、オオレンは根
茎、オオバク、ケイヒは樹皮、セージ、センブリ、シャ
ゼンソウ(オオバコ)は全草、ハマメリスは葉、樹皮又
は根、バーチは葉又は樹皮、ニンニクは鱗茎、カミツレ
は花、ウイキョウ、椿は実、ホップは雌花穂果、チンピ
(ミカンの果皮)、ボタンピ(ボタンの根)、クジン
(クララの根)、ソウハクヒ(桑の根)、オウゴン(コ
ガネバナの根)を、水、アルコール(メタノール、エタ
ノール等)、含水アルコール、多価アルコール(プロピ
レングリコール、1,3ブチレングリコール、ポリエチ
レングリコール等)、含水多価アルコール、その他の有
機溶媒溶媒(石油エーテル、シクロヘキサン、アセト
ン、ベンゼン、四塩化炭素等)で抽出した抽出物、及び
/又は抽出物を更に精製したもの、あるいは精製したも
のを更に分画したものであり、本発明では抽出液、濃縮
液、乾燥末のいずれも配合することが出来る。その中で
好ましくは、桃の葉の1,3ブチレングリコール抽出
物、高麗ニンジンの根、ヘチマの葉、アロエの葉、オウ
ゴンの根のエタノール抽出物、茶の実を含水低級アルコ
ールで抽出したものをイオン交換カラムで更に分画処理
して得られる抽出物(特公平5−52287号公報)、
椿の実の含水低級アルコールで抽出したものをイオン交
換カラムで更に分画処理して得られる抽出物(特公平6
−693号公報)である。On the other hand, examples of the above-mentioned plant extract used as the component (b) in the present invention include loquat, peach, aloe, leaves in ginkgo, tea leaves or fruits, ginseng, peony, valerian root, purple mulberry. , Bellflowers are roots, loofah, genus ginger, odorum serrata, bamboo are aboveground parts, oren are rhizomes, psyllium, cinnamon bark, sage, senburi, psyllium (psyllium) are whole plants, hamamelis leaves, bark or roots, birch leaves or Bark, garlic bulbs, chamomile flowers, fennel, camellia fruits, hops female spikes, chimpi (citrus peels), button pi (button roots), kujin (clara roots), sohakuhi (mulberry roots), Scuttlefish (root of Scutellaria baicalensis), water, alcohol (methanol, ethanol, etc.), hydrous alcohol, polyhydric alcohol (propylene glycol, 1,3 Renglycol, polyethyleneglycol, etc.), hydrous polyhydric alcohol, other organic solvent solvents (petroleum ether, cyclohexane, acetone, benzene, carbon tetrachloride, etc.) extracted and / or further purified extract, Alternatively, it is a product obtained by further fractionating a purified product, and in the present invention, any of an extract, a concentrate, and a dried powder can be blended. Of these, preferably, 1,3 butylene glycol extract of peach leaves, root of ginseng root, loofah leaves, aloe leaves, root of algonum, ethanol extract of tea, tea fruit extracted with hydrous lower alcohol An extract obtained by further fractionating an ion-exchange column (Japanese Patent Publication No. 5-52287),
An extract obtained by subjecting camellia seeds extracted with hydrous lower alcohol to fractionation with an ion exchange column (Patent Literature 6
-693).
【0010】上記の植物抽出物の皮膚化粧料への配合量
(乾燥残分換算)は、皮膚化粧料全量に対して、0.0
1〜10wt%が好ましい。0.01wt%未満では本
発明の効果が十分に発揮されず、10wt%を超えて配
合しても、配合量の増加に見合った効果が期待出来ない
場合があるとともに、皮膚トラブルの懸念を生じる場合
がある。The amount of the above-mentioned plant extract to be added to the skin cosmetics (calculated as dry residue) is 0.0.
1 to 10 wt% is preferable. If the amount is less than 0.01 wt%, the effect of the present invention is not sufficiently exerted, and if the amount exceeds 10 wt%, the effect commensurate with the increase in the amount of the compound may not be expected, and the skin trouble may occur. There are cases.
【0011】又、本発明で(b)成分として使用する、
酵母粉末、酵母抽出物としては、(1)ビール酵母やパ
ン酵母等の酵母の自己消化によって得られる消化液の噴
霧乾燥物、(2)乾燥酵母の自己消化によって得られた
消化液をミクロフィルターにより、無菌的にろ過後、凍
結乾燥したものを精製水で希釈したもの、(3)酵母の
自己消化によって得られる消化液を濃縮乾燥したものか
らプロピレングリコール、1,3ブチレングリコール、
水で抽出して得られたもの、(4)酵母の菌体を乾燥し
て粉末にしたものから水、濃グリセリンの混合液で抽出
して得られたもの、(5)酵母を酸で加水分解した後、
遠心分離、透析、ろ過、濃縮により得られたものであ
り、各種アミノ酸、ビタミン、核酸関連物質、蛋白質、
糖質、脂質を多く含んでいる。市販されているものとし
ては、酵母エキスA−33(日光ケミカルズ社製)、L
p酵母(サンレード社製)等がある。Further, used as the component (b) in the present invention,
As the yeast powder and yeast extract, (1) a spray-dried product of a digestive solution obtained by autolysis of yeast such as brewer's yeast and baker's yeast, (2) a microfilter of the digestive solution obtained by autolysis of dry yeast. By aseptic filtration, lyophilized, diluted with purified water, and (3) propylene glycol, 1,3 butylene glycol, obtained by concentrating and drying the digested liquid obtained by yeast autolysis.
The product obtained by extracting with water, (4) the product obtained by drying yeast cells into powder, and extracting with a mixed solution of water and concentrated glycerin, (5) hydrolyzing yeast with acid. After disassembling,
It is obtained by centrifugation, dialysis, filtration, and concentration, and various amino acids, vitamins, nucleic acid-related substances, proteins,
Contains a lot of sugars and lipids. As commercially available products, yeast extract A-33 (manufactured by Nikko Chemicals), L
p yeast (manufactured by SunRade) and the like.
【0012】上記の酵母粉末、酵母の溶媒抽出物の配合
量(乾燥残分換算)は、皮膚化粧料全量に対して、0.
01〜5.0wt%が好ましい。0.01wt%未満で
は本発明の効果が十分に発揮されず、5wt%を超えて
配合しても、配合量の増加に見合った効果が期待出来な
い場合があるとともに、皮膚トラブルの懸念を生じる場
合がある。The amount of the yeast powder and the solvent extract of yeast described above (converted to the dry residue) is 0.
01-5.0 wt% is preferable. If it is less than 0.01 wt%, the effect of the present invention is not sufficiently exerted, and if it exceeds 5 wt%, the effect commensurate with the increase of the blending amount may not be expected, and there is a concern of skin trouble. There are cases.
【0013】更に、本発明で(b)成分として使用す
る、哺乳動物の血液からの除蛋白抽出物とは、特公昭4
4−13956号公報等によって製造されるものであ
り、牛、豚等の新鮮な血液を限外ろ過法等により除蛋白
して得られる水溶解性成分であり、アミノ酸、ペプタイ
ド、有機酸、糖質を多く含んでいる。市販のものとして
は、スティミュセル(ペタファーム社製)、ソルコセリ
ル(東菱薬品社製)等がある。又、本発明で使用するコ
ラーゲンとは、動物の結合組織の主蛋白質であって、牛
等の皮膚や真皮層を抽出処理するか、又はこれを加水分
解することにより得られる可溶性コラーゲン及び加水分
解コラーゲン、又はこれを更にサクシニル化等の処理し
たものが挙げられる。市販されているものとしては、、
Crotein CAA S.F.(Croda社
製)、プロモイスW(成和化成社製)、アテロコラーゲ
ンSS(高研社製)等がある。Further, the deproteinized extract from mammalian blood used as the component (b) in the present invention is Japanese Patent Publication No.
It is a water-soluble component obtained by deproteinizing fresh blood of cattle, pigs, etc. by an ultrafiltration method and the like, which is produced by JP-A-4-13956, and amino acids, peptides, organic acids and sugars. Contains a lot of quality. Examples of commercially available products include Stimulusel (manufactured by Petafarm) and Solcoceryl (manufactured by Toryo Yakuhin). Further, the collagen used in the present invention is a main protein of connective tissue of animals, and soluble collagen and hydrolyzate obtained by subjecting the skin or dermis layer of cattle or the like to an extraction treatment or hydrolyzing the same. Collagen, or a product obtained by further treating it with succinylation or the like can be mentioned. As commercially available products,
Protein CAA S.M. F. (Manufactured by Croda), Promois W (manufactured by Seiwa Kasei), and Atelocollagen SS (manufactured by Koken Co.).
【0014】上記の哺乳動物の血液からの除蛋白抽出
物、コラーゲンの配合量(乾燥残分換算)は、皮膚化粧
料全量に対して、0.01〜5.0wt%が好ましい。
0.01wt%未満では本発明の効果が十分に発揮され
ず、5.0wt%を超えて配合しても、配合量の増加に
見合った効果が期待出来ない場合があるとともに、皮膚
トラブルの懸念を生じる場合がある。The amount of the deproteinized protein extract from the blood of mammals and the collagen content (calculated as dry residue) is preferably 0.01 to 5.0 wt% with respect to the total amount of the skin cosmetic.
If it is less than 0.01 wt%, the effect of the present invention is not sufficiently exerted, and even if it exceeds 5.0 wt%, the effect commensurate with the increase of the blended amount may not be expected, and there is a concern of skin trouble. May occur.
【0015】本発明の皮膚化粧料の剤型は、特に限定さ
れるものでなく、クリーム状、乳液状、ローション状、
軟膏状、パウダー状等々の通常の医薬品、医薬部外品、
化粧料の剤型に適用することが出来る。本発明の皮膚外
用剤には、他の成分として、乳化剤、油性物質、保湿
剤、増粘剤、香料、防腐剤、抗酸化剤、着色剤等を本発
明の目的を達成する範囲内で適宜配合し得る。The dosage form of the skin cosmetic of the present invention is not particularly limited, and may be cream, emulsion, lotion,
Ointments, powders, etc. of ordinary pharmaceuticals, quasi-drugs,
It can be applied to cosmetic formulations. In the external preparation for skin of the present invention, as other components, an emulsifier, an oily substance, a moisturizer, a thickener, a fragrance, an antiseptic, an antioxidant, a colorant and the like are appropriately added within a range to achieve the object of the present invention. It may be blended.
【0016】[0016]
【実施例】以下、実施例、及び比較例に基づいて本発明
を詳細に説明する。尚、実施例に記載の(1)角質層の
ターンオーバー速度測定方法、(2)荒れ肌改善効果の
測定方法、(3)角質改善効果の測定方法、(4)官能
テストは下記の通りである。The present invention will be described below in detail based on examples and comparative examples. In the Examples, (1) the method for measuring the turnover speed of the stratum corneum, (2) the method for measuring the effect of improving rough skin, (3) the method for measuring the effect of improving stratum corneum, and (4) the sensory test are as follows. .
【0017】(1)角質層のターンオーバー速度測定方
法 蛍光色素のダンシルクロリドを白色ワセリン中に5wt
%配合した軟膏を作り、被験者20名の前腕部の皮膚に
24時間閉塞塗布し、角質層にダンシルクロリドを浸透
結合させた。その後、同じ部位に1日2回(朝、夕)被
験試料を塗布し、毎日ダンシルクロリドの蛍光を調べ、
その蛍光が消滅するまでの日数を皮膚角質層のターンオ
ーバー速度とした。測定結果は各被験者の日数の平均値
で示した。尚、通常の皮膚角質層のターンオーバーは1
4〜16日であるが、老化した皮膚においては18日前
後に延びる。それに対して老化防止効果が現れると12
日前後にまで短縮される。(1) Method for measuring turnover rate of stratum corneum 5 wt% of dansyl chloride as a fluorescent dye in white petrolatum
% Ointment was prepared and occluded and applied to the skin of the forearm of 20 subjects for 24 hours, and dansyl chloride was osmotically bonded to the stratum corneum. Thereafter, the test sample was applied to the same site twice a day (morning and evening), and the fluorescence of dansyl chloride was examined every day.
The number of days until the fluorescence disappeared was defined as the skin stratum corneum turnover speed. The measurement results were shown as an average of the number of days for each subject. The normal skin stratum corneum turnover is 1
4-16 days, but extends around 18 days in aged skin. On the other hand, when the anti-aging effect appears, 12
It is shortened to around days.
【0018】(2)荒れ肌改善効果の測定方法 下脚に荒れ肌を有する中高年被験者20名を対象として
4週間連続塗布効果を調べた。即ち、被験者の左側下脚
試験部位に1日2回(朝、夕)被験試料を塗布し、試験
開始前および終了後の皮膚の状態を下記表1の判定基準
により判定した。尚、右側下脚は被験試料を塗布せず対
照とした。(2) Method for measuring the effect of improving rough skin The effect of continuous application was investigated for 20 weeks for 20 middle-aged and elderly subjects who have rough skin on their lower legs. That is, the test sample was applied twice a day (morning and evening) to the left lower leg test site of the test subject, and the skin condition before and after the test was judged according to the criteria shown in Table 1 below. The lower leg on the right side was used as a control without applying the test sample.
【0019】[0019]
【表1】 [Table 1]
【0020】そして試験前後の試験部位と対照部位の判
定結果を比較し、皮膚乾燥度が2段階以上改善された場
合(例えば:+→−、++→±)を「有効」、1段階改
善された場合を「やや有効」、変化がなかった場合を
「無効」とした。試験結果は「有効」、「やや有効」と
なった被験者の人数で示した。Then, the judgment results of the test site before and after the test and the control site are compared, and when the skin dryness is improved by two stages or more (for example: + →-, ++ → ±), it is “effective” and improved by one stage. When the result is "slightly valid", when there is no change, it is considered "invalid". The test results are shown by the number of subjects who were “effective” and “somewhat effective”.
【0021】(3)角質改善(角質細胞の抗剥離性増
大)効果の測定方法 前記の荒れ肌改善測定試験開始前後及び終了後の被験部
皮膚にスコッチテープ(ニチバン社メンディングテー
プ)を接着し、これを剥離したときテープに付着した角
質細胞の状態を走査型電子顕微鏡によって詳細に調べ、
下記表2の判定基準によって皮膚角質層細胞剥離性を分
類し、角質改善効果を求めた。(3) Method for measuring the effect of improving keratin (increasing anti-peeling property of keratinocytes) Scotch tape (Nichiban Mending Tape) is adhered to the skin of the test area before and after the start of and the end of the rough skin improvement measurement test. When this is peeled off, the state of keratinocytes attached to the tape is examined in detail by a scanning electron microscope,
The stratum corneum exfoliating property was classified according to the criteria shown in Table 2 below, and the effect of improving the keratin was determined.
【0022】[0022]
【表2】 [Table 2]
【0023】判定は4週間連続塗布後の試験部位の評価
点と対照部位のそれとの差が2点以上の場合を「有
効」、1点以上の場合を「やや有効」、0点の場合を
「無効」とした。試験結果は「有効」、「やや有効」と
なった被験者の人数で示した。The judgment is “effective” when the difference between the evaluation points of the test site and the control site after continuous application for 4 weeks is 2 or more, “effective”, 1 or more is “slightly effective”, and 0 is 0. "Invalid" The test results are shown by the number of subjects who were “effective” and “somewhat effective”.
【0024】(4)官能テスト(美肌効果) 荒れ肌、小じわ、乾燥肌等を訴える女子被験者(35〜
55才)20人に被験試料を1日2回(朝、夕)連続3
ケ月間塗布して、1、2、3ケ月後の効果を評価した。
試験結果は、皮膚の湿潤性、平滑性、弾力性の各項目に
対して、「皮膚に潤いが生じた」、「皮膚が滑らかにな
った」と回答した人数で示した。(4) Sensory test (Beautiful skin effect) Female subjects who complain of rough skin, fine wrinkles, dry skin (35-35)
Test sample twice a day (morning, evening) for 20 persons 3
The coating was applied for 1 month, and the effect after 1, 2 and 3 months was evaluated.
The test results are shown by the number of people who responded that "the skin was moisturized" and "the skin became smooth" for each of the items of wettability, smoothness, and elasticity of the skin.
【0025】実施例1〜6、比較例1〜9(スキンクリ
ーム) (a)成分のメバロン酸、メバロン酸ラクトン、(b)
成分のアロエの葉抽出物、桃の葉抽出物、椿の実抽出
物、茶の実抽出物、オウゴンの根抽出物、ビワの葉抽出
物を表3〜4の如く配合し、各々のスキンクリームを調
製し、前記の諸実験を実施した。Examples 1 to 6 and Comparative Examples 1 to 9 (skin cream) (a) component mevalonic acid, mevalonic acid lactone, (b)
Aloe leaf extract, peach leaf extract, camellia seed extract, tea seed extract, sardine root extract, loquat leaf extract as ingredients are blended as shown in Tables 3 to 4, and each skin is blended. Creams were prepared and the above experiments were carried out.
【0026】(1)組成(1) Composition
【0027】[0027]
【表3】 [Table 3]
【0028】(2)調製方法 上記表3の原料(A)を70℃で溶解し、原料(B)と
混合した後、78℃にした。次いでこれを、75℃に加
熱した原料(C)へ攪拌しなが徐々に加え、予備乳化を
行った。その後ホモジナイザーにかけて乳化を完全に行
い、50℃に冷却後、原料(D)を添加し、30℃まで
冷却し、スキンクリームを調製した。尚、(a)成分と
して配合したR(−)−メバロン酸ラクトンは、スキン
クリーム中でR(−)−メバロン酸と平衡状態で存在し
ていると考えられる。(2) Preparation Method The raw material (A) in Table 3 above was melted at 70 ° C., mixed with the raw material (B), and then heated to 78 ° C. Next, this was gradually added to the raw material (C) heated to 75 ° C. while stirring, and preliminarily emulsified. Thereafter, the mixture was completely emulsified with a homogenizer, cooled to 50 ° C., added with the raw material (D), and cooled to 30 ° C. to prepare a skin cream. The R (-)-mevalonic acid lactone blended as the component (a) is considered to be present in the skin cream in equilibrium with R (-)-mevalonic acid.
【0029】(3)特性 上記の各スキンクリームについて諸試験を実施し、その
結果を表4、5に示す。(3) Characteristics Various tests were conducted on each of the above skin creams, and the results are shown in Tables 4 and 5.
【0030】[0030]
【表4】 [Table 4]
【0031】[0031]
【表5】 [Table 5]
【0032】表4、5に示す様に、(a)成分のメバロ
ン酸、メバロン酸ラクトン、(b)成分のアロエの葉抽
出物、桃の葉抽出物、椿の実抽出物、茶の実抽出物、オ
ウゴンの根抽出物、ビワの葉抽出物を無配合、又は単独
配合した比較例1〜9のスキンクリームは諸特性におい
て十分なる効果が得られないが、一方、本発明の実施例
1〜6である(a)メバロン酸、メバロン酸ラクトン
と、(b)成分のアロエの葉抽出物、桃の葉抽出物、椿
の実抽出物、茶の実抽出物、オウゴンの根抽出物、ビワ
の葉抽出物とを併用した実施例1〜6のスキンクリーム
は、荒れ肌改善効果、角質改善効果、ターンオーバー速
度を早くする効果、すなわち、皮膚の老化防止効果にお
いて顕著な効果が認められ、官能テストでも塗布後2ケ
月で、湿潤性、平滑性、弾力性が認められた。As shown in Tables 4 and 5, (a) component mevalonic acid, mevalonic acid lactone, (b) component aloe leaf extract, peach leaf extract, camellia fruit extract, tea fruit The skin creams of Comparative Examples 1 to 9 which did not contain the extract, the root extract of Scutellaria basil, and the loquat leaf extract, or which contained the extract alone, did not show sufficient effects in various properties, while the Examples of the present invention were used. 1 to 6 of (a) mevalonic acid and mevalonic acid lactone, and (b) component of aloe leaf extract, peach leaf extract, camellia fruit extract, tea fruit extract, sorghum root extract The skin creams of Examples 1 to 6 which were used in combination with the loquat leaf extract were found to have a remarkable effect on rough skin improving effect, keratin improving effect, quick turnover speed effect, that is, the effect of preventing skin aging. , Sensory test, 2 months after application, wetting, smooth , Elasticity was observed.
【0033】実施例7、比較例10〜11(スキンロー
ション) 下記表6の組成により、各々のスキンローションを調製
して諸試験を実施した。尚、酵母抽出物(配合量は乾燥
残分換算)としては、酵母エキスA−33(日光ケミカ
ルズ社製)を使用した。Example 7, Comparative Examples 10 to 11 (Skin Lotion) Each skin lotion was prepared according to the composition shown in Table 6 below, and various tests were carried out. In addition, yeast extract A-33 (manufactured by Nikko Chemicals Co., Ltd.) was used as the yeast extract (compounding amount converted to dry residue).
【0034】(1)組成(1) Composition
【0035】[0035]
【表6】 [Table 6]
【0036】(2)調製方法 上記表6の各原料を撹拌し均一に溶解してスキンローシ
ョンを調製した。 (3)特性 上記実施例7のスキンローションは比較例10〜11に
比べ、優れた美肌効果と皮膚老化防止効果(荒れ肌改善
効果、角質改善効果、ターンオーバー速度を早くする効
果)が得られた。(2) Preparation Method Each of the raw materials shown in Table 6 above was stirred and uniformly dissolved to prepare a skin lotion. (3) Characteristics The skin lotion of Example 7 had excellent skin beautifying effect and skin aging preventing effect (rough skin improving effect, keratin improving effect, effect of accelerating turnover speed) as compared with Comparative Examples 10 to 11. .
【0037】実施例8(スキンクリーム) 下記表7の組成にてスキンクリームを調製した。尚、哺
乳動物の血液の除蛋白抽出物(配合量は乾燥残分換算)
としては、ソルコセリル(東菱薬品社製)を使用した。Example 8 (Skin Cream) A skin cream having the composition shown in Table 7 below was prepared. Deproteinized extract of mammalian blood (blending amount converted to dry residue)
Solcoceryl (manufactured by Tohryo Pharmaceutical Co., Ltd.) was used as.
【0038】[0038]
【表7】 [Table 7]
【0039】(2)調製方法 表7に記載の原料(A)、及び原料(B)を均一に加熱
溶解して温度を80℃にした。次いで、(A)中に、
(B)を注入乳化した後、撹拌しながら30℃まで冷却
し、スキンクリームを調製した。(2) Preparation method The raw material (A) and the raw material (B) shown in Table 7 were uniformly heated and melted to bring the temperature to 80 ° C. Then, during (A),
After injecting and emulsifying (B), it was cooled to 30 ° C. with stirring to prepare a skin cream.
【0040】実施例9(メイクアップベース) 下記表8の組成にてメイクアップベースを調製した。
尚、加水分解コラーゲン(配合量は乾燥残分換算)とし
ては、プロモイスW(成和化成社製)を使用した。 (1)組成Example 9 (makeup base) A makeup base having the composition shown in Table 8 below was prepared.
As the hydrolyzed collagen (compounding amount was calculated as dry residue), Promois W (manufactured by Seiwa Kasei Co., Ltd.) was used. (1) Composition
【0041】[0041]
【表8】 [Table 8]
【0042】(2)調製方法 表8に記載の原料(A)、及び原料(B)を均一に加熱
溶解して温度を80℃にした。次いで、(B)液をホモ
ミキサーにて撹拌しながら、(A)液を注入乳化した
後、30℃まで冷却し、メイクアップベースを調製し
た。(2) Preparation method The raw material (A) and the raw material (B) shown in Table 8 were uniformly heated and melted to bring the temperature to 80 ° C. Next, while stirring the liquid (B) with a homomixer, the liquid (A) was injected and emulsified, and then cooled to 30 ° C. to prepare a makeup base.
【0043】実施例10(スキンミルク) 下記表9の組成にてスキンミルクを調製した。尚、
(b)成分の植物抽出物の配合量は乾燥残分換算であ
る。 (1)組成Example 10 (skin milk) A skin milk having the composition shown in Table 9 below was prepared. still,
The blending amount of the plant extract of the component (b) is in terms of dry residue. (1) Composition
【0044】[0044]
【表9】 [Table 9]
【0045】(2)調製方法 表9に記載の原料(A)、及び原料(B)を均一に加熱
溶解して温度を80℃にした。次いで、(A)液中に、
(B)液を注入乳化した後、撹拌しながら30℃まで冷
却し、スキンミルクを調製した。(2) Preparation method The raw material (A) and the raw material (B) shown in Table 9 were uniformly heated and melted to bring the temperature to 80 ° C. Then, in the (A) liquid,
After injecting and emulsifying the liquid (B), it was cooled to 30 ° C. with stirring to prepare skin milk.
【0046】上記実施例8〜10の(a)成分と(b)
成分を併用したものは、(a)成分、又は(b)成分の
みを配合したものに比べ、優れた皮膚老化防止効果(荒
れ肌改善効果、角質改善効果、ターンオーバー速度を早
くする効果)、美肌効果を示した。Components (a) and (b) of Examples 8 to 10 above
The combined use of the components has a superior effect of preventing skin aging (effect of improving rough skin, effect of improving keratin, effect of accelerating turnover speed), and beautiful skin, as compared with those in which only component (a) or component (b) is blended. Showed the effect.
【0047】[0047]
【発明の効果】以上記載の如く、本発明が、皮膚老化防
止効果(荒れ肌改善効果、角質改善効果、ターンオーバ
ー速度を速くする効果)、美肌効果に優れた有用な皮膚
化粧料を提供することは明らかである。As described above, the present invention provides a useful skin cosmetic excellent in skin aging prevention effect (rough skin improvement effect, keratin improvement effect, turnover speed increasing effect) and skin beautiful effect. Is clear.
Claims (3)
の一種以上と、(b)ビワ、桃、アロエ、高麗ニンジ
ン、ヘチマ、芍薬、オオレン、オオバク、ボタンピ、ゲ
ンノショウコ、茶、クジン、オドリコソウ、セージ、ハ
マメリス、バーチ、ニンニク、チンピ、カミツレ、シャ
ゼンソウ、桔梗、ケイヒ、ウイキョウ、ホップ、カノコ
ソウ、オウゴン、ムラサキ、セージ、銀杏、竹、ソウハ
クヒ、センブリ、椿からなる群の一種以上から選ばれる
植物抽出物とを含有する皮膚化粧料。1. (a) one or more of mevalonic acid and mevalonic acid lactone, and (b) loquat, peach, aloe, ginseng, loofah, peony, oleen, psyllium, button pi, gem ginger, tea, kujin, sardine, sage. , Plant extract selected from one or more of the group consisting of, hamamelis, birch, garlic, chimpanzee, chamomile, chazensou, bellflower, cinnamon, fennel, hop, valerian, dragonfly, murasaki, sage, ginkgo, bamboo, sowakuhi, senburi, camellia. A skin cosmetic containing and.
の一種以上と、(b)酵母粉末、酵母抽出物の一種以上
とを含有する皮膚化粧料。2. A skin cosmetic containing (a) one or more of mevalonic acid and mevalonic acid lactone, and (b) one or more of yeast powder and yeast extract.
の一種以上と、(b)哺乳動物の血液からの除蛋白抽出
物、コラーゲンの一種以上とを含有する皮膚化粧料。3. A skin cosmetic containing (a) one or more of mevalonic acid and a mevalonic acid lactone, and (b) one or more of a deproteinized extract from mammalian blood and collagen.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15773096A JP3534945B2 (en) | 1996-05-28 | 1996-05-28 | Skin cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15773096A JP3534945B2 (en) | 1996-05-28 | 1996-05-28 | Skin cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH09315930A true JPH09315930A (en) | 1997-12-09 |
| JP3534945B2 JP3534945B2 (en) | 2004-06-07 |
Family
ID=15656114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP15773096A Expired - Lifetime JP3534945B2 (en) | 1996-05-28 | 1996-05-28 | Skin cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3534945B2 (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001072567A (en) * | 1999-09-07 | 2001-03-21 | Sunstar Inc | Skin cosmetic |
| JP2006265232A (en) * | 2005-02-22 | 2006-10-05 | Maruzen Pharmaceut Co Ltd | Skin cosmetic |
| JP2008007412A (en) * | 2006-06-27 | 2008-01-17 | Maruzen Pharmaceut Co Ltd | Involucrin production promoter and epidermal keratinization normalizing agent |
| US7556828B2 (en) * | 2003-03-28 | 2009-07-07 | Zuguang Zhang | Pharmaceutical composition for treatment of BPH and preparation thereof |
| KR100946690B1 (en) * | 2007-12-20 | 2010-03-12 | 한국콜마 주식회사 | Cosmetic composition having an anti-inflammatory effect containing fermented extracts of organic tomatoes, plums, dermis, peaches and aloe |
| JP2010105970A (en) * | 2008-10-31 | 2010-05-13 | Nof Corp | Estrogenic action agent and external preparation for skin containing the same |
| JP2018070524A (en) * | 2016-10-31 | 2018-05-10 | 株式会社ノエビア | Epidermal cell activator |
| KR102683428B1 (en) * | 2024-03-28 | 2024-07-10 | (주)트윈켐 | Cosmetic composition for improving sebum, skin pores, dead skin cells, and skin acne |
-
1996
- 1996-05-28 JP JP15773096A patent/JP3534945B2/en not_active Expired - Lifetime
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001072567A (en) * | 1999-09-07 | 2001-03-21 | Sunstar Inc | Skin cosmetic |
| US7556828B2 (en) * | 2003-03-28 | 2009-07-07 | Zuguang Zhang | Pharmaceutical composition for treatment of BPH and preparation thereof |
| JP2006265232A (en) * | 2005-02-22 | 2006-10-05 | Maruzen Pharmaceut Co Ltd | Skin cosmetic |
| JP2008007412A (en) * | 2006-06-27 | 2008-01-17 | Maruzen Pharmaceut Co Ltd | Involucrin production promoter and epidermal keratinization normalizing agent |
| KR100946690B1 (en) * | 2007-12-20 | 2010-03-12 | 한국콜마 주식회사 | Cosmetic composition having an anti-inflammatory effect containing fermented extracts of organic tomatoes, plums, dermis, peaches and aloe |
| JP2010105970A (en) * | 2008-10-31 | 2010-05-13 | Nof Corp | Estrogenic action agent and external preparation for skin containing the same |
| JP2018070524A (en) * | 2016-10-31 | 2018-05-10 | 株式会社ノエビア | Epidermal cell activator |
| KR102683428B1 (en) * | 2024-03-28 | 2024-07-10 | (주)트윈켐 | Cosmetic composition for improving sebum, skin pores, dead skin cells, and skin acne |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3534945B2 (en) | 2004-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4918202B2 (en) | Skin composition | |
| JP2002020225A (en) | Humectant composition | |
| JP4299374B2 (en) | Cell activator and its application | |
| JP4915714B2 (en) | Collagen gel contraction promoter | |
| KR102428341B1 (en) | Composition for the natural surfactant and cosmetic composition containing Saponaria officinalis, Yucca Schidigera and Quillaia saponaria MOLINA | |
| JPS61271210A (en) | Cosmetic | |
| JPH049316A (en) | Whitening cosmetic | |
| JPS5916816A (en) | External composition | |
| JPH09315930A (en) | Cosmetic material for skin | |
| JPH06336422A (en) | External skin preparation | |
| JPH10114670A (en) | Composition suitable for external use | |
| CN120360880A (en) | Active peptide composition and application thereof in preparation of anti-aging and wrinkle-removing products | |
| JPH01102011A (en) | Skin cosmetic | |
| JP2021113172A (en) | Peptidyl arginine deiminase 1 expression promoter | |
| JP2002284632A (en) | Superoxide anion scavenger containing sake lees as an active ingredient | |
| JP3507635B2 (en) | Composition suitable for external use | |
| KR101953676B1 (en) | Cosmetic composition for skin moisturizing containing ultrasonicating extract of harpagophytum procumbens | |
| JPH04321615A (en) | Skin medicine for external use | |
| JP2009249366A (en) | Collagen production promotor and anti-aging skin preparation for external use | |
| WO2002051374A1 (en) | Hair growth inhibitors and compositions containing the same | |
| JP3390549B2 (en) | Skin cosmetics | |
| JP2002284648A (en) | Hair restorer composition | |
| JP4222973B2 (en) | Elastase activity inhibitors and cosmetics | |
| JP2002179584A (en) | Testosterone 5α-reductase inhibitor and androgen receptor binding inhibitor, hair preparation and skin cosmetic | |
| WO1999009945A1 (en) | Use of the rhoeo discolor plant extracts in cosmetics and pharmaceutics, in particular in dermatology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20040309 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040310 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080319 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090319 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090319 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100319 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100319 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110319 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110319 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120319 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120319 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130319 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130319 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140319 Year of fee payment: 10 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |